Adjuvant vaccination with melanoma antigen pulsed dendritic cells (DCs) in stage III melanoma patients

9039 Background: This is a pilot study evaluating of high-risk melanoma patients (pts) treated with peptide-DC vaccine after lymphadenectomy (LND). DC vaccination was designed to induce the immune ...